Cargolux Airlines has successfully passed its GDP (Good Distribution Practice) surveillance audit. The certification attests that the company’s quality management system fulfils the latest requirements of the EU Directive ‘Guidelines on Good Distribution Practice of Medicinal Products for Human Use’ and of WHO Guidelines.
The certification reflects the airline’s strong commitment to high standards when handling pharmaceutical and healthcare products. This dedication was particularly salient in 2020 with the increased demand for pharmaceutical and health care shipments, including vaccines and related material. Cargolux’s engagement towards seamless pharma transports remained intact during this period, making the airline a leading partner for healthcare-related transport solutions.
